TrialAmerican journal of hematology2016

Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase.

Gregory M Pastores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.